ADME Toxicology Testing Market: Drivers and Market Evolution

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Projected Increase In Market Value Of The ADME Toxicology Testing Market During 2026–2030?

The adme toxicology testing market has experienced rapid expansion over recent years. It is projected to increase from $11.5 billion in 2025 to $12.83 billion in 2026, achieving a compound annual growth rate (CAGR) of 11.6%. The historical growth can be ascribed to several factors, including the limited availability of automated ADME testing systems, a dependency on traditional biochemical assays, an increasing regulatory focus on drug safety, growing pharmaceutical research initiatives, and the adoption of LC-MS and HPLC instruments.

The adme toxicology testing market is projected to experience substantial expansion in the coming years. This market is anticipated to reach a valuation of $20.25 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 12.1%. Factors contributing to this growth during the forecast period include the evolution of integrated adme platforms, the expanding utilization of omics and molecular imaging technologies, increased capital allocation towards predictive toxicology software, the broader implementation of adme testing in the cosmetics and food sectors, and the embrace of AI-powered risk assessment solutions. Key trends anticipated for the forecast timeframe encompass the increasing deployment of high-throughput screening instruments, the enhanced application of cell-based and in vitro assays, a surge in demand for omics-based toxicology technologies, the broader integration of adme testing within pharmaceutical development, and the incorporation of simulation and modeling software for risk assessment.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/adme-toxicology-testing-global-market-report

Which Strong Drivers Are Impacting The ADME Toxicology Testing Market Growth?

The increasing need for novel drugs is projected to fuel the expansion of the ADME toxicology testing market in the future. Novel drugs are defined as pharmaceutical substances not previously approved or sold for therapeutic use. ADME toxicity testing is a vital phase in drug development, ensuring that these new drugs are safe and do not generate harmful toxins within the body. For example, in January 2024, the New Drug Therapy Approvals 2023 report from the Center for Drug Evaluation and Research (CDER), a US-based branch of the U.S. Food and Drug Administration (FDA), revealed that CDER approved 55 novel drugs in 2023, with 20 (36%) classified as first-in-class, an increase from 37 novel drug approvals in 2022. Consequently, the rising demand for novel drugs is propelling the growth of the ADME toxicology testing market. The expansion of the pharmaceutical industry is anticipated to drive the ADME toxicology testing market forward. This industry encompasses the discovery, development, and manufacture of drugs and medicines by both governmental and private entities. The pharmaceutical sector employs ADME toxicology testing to evaluate the absorption, distribution, metabolism, and excretion (ADME) characteristics of potential drug candidates and to gauge their potential toxicity. This testing is essential for forecasting how a drug will act inside the human body, including its absorption rates, distribution to target tissues, metabolic pathways, and elimination. For instance, in June 2023, the European Federation of Pharmaceutical Industries and Associations (EFPIA), a Belgium-based trade association representing Europe’s pharmaceutical industry, reported that Europe’s total pharmaceutical production reached €390,000 million ($422,803 million) in 2023, marking an increase from €363,300 million ($393,857 million) in 2022. Thus, the expanding pharmaceutical industry is a significant driver for the growth of the ADME toxicology testing market.

How Is The ADME Toxicology Testing Market Categorized Across Its Segment Groups?

The adme toxicology testing market covered in this report is segmented –

1) By Product Type: Instruments, Software Solutions, Assays Systems, Reagents, Other Product Types

2) By Method: Cellular Assay, Biochemical Assay, In Silica, Ex-Vivo

3) By Technology: Cell Culture, High Throughput, Molecular Imaging, OMICS Technology, Other Technologies

4) By Application: Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity, Other Applications

5) By End-User: Cosmetics And Household Products, Pharmaceutical Industry, Animal Industry, Food Industry, Other End Users

Subsegments:

1) By Instruments: High-Throughput Screening Instruments, LC-MS Or MS (Liquid Chromatography-Mass Spectrometry), HPLC (High-Performance Liquid Chromatography), Automated Workstations

2) By Software Solutions: Data Management Software, Simulation And Modeling Software, Risk Assessment Software

3) By Assay Systems: Cell-Based Assays, In Vitro Assays, Bioanalytical Assays

4) By Reagents: Biochemicals, Buffer Solutions, Culture Media

5) By Other Products: Kits And Consumables, Analytical Standards

Which Trends Are Contributing To Changes In The ADME Toxicology Testing Market?

Major companies operating in the ADME toxicology testing market are integrating advanced technologies, such as the Cyprotex e-Store, to enable online ordering of ADME-Tox services. These ADME-Tox services aim to conserve development costs and time, lessen the likelihood of failure at a subsequent stage, and facilitate the selection of the most suitable candidate for clinical development. For instance, in October 2023, Evotec SE, a Germany-based biotechnology company, introduced the Cyprotex e-Store, an e-commerce platform designed to offer simplified online access to the company’s comprehensive range of ADME-Tox services. The e-Store streamlines and accelerates the purchasing process, allowing registered users to evaluate and order Cyprotex’ offerings around the clock, seven days a week. It provides instant online access to prices and detailed protocols, and users can effortlessly place orders, track their progress, and reorder as needed. This efficient platform reduces the lead time for services, enabling users to receive their data quicker.

Which Firms Are Influencing Competition In The ADME Toxicology Testing Market?

Major companies operating in the adme toxicology testing market are AbbVie Inc., Thermo Fisher Scientific Inc., Boehringer Ingelheim GmbH, Laboratory Corporation of America Holdings, Corning Incorporated, Eurofins Scientific SE, Agilent Technologies Inc., Lonza Group AG, Dassault Systèmes SE, Catalent Inc., Charles River Laboratories International Inc., Beckman Coulter Inc., PerkinElmer Inc., Bio-Rad Laboratories Inc., Curia Global Inc, Promega Corporation, Takara Bio Inc, AB Sciex LLC, QPS Holdings LLC, Simulations Plus Inc., Cyprotex, XenoTech LLC, BioIVT LLC, Absorption Systems, Creative Bioarray, SOLVO Biotechnology Rt., Creative Biolabs Inc, Gentronix Limited, Admecell Inc., Molecular Discovery Ltd.

Get The Full ADME Toxicology Testing Market Report:

https://www.thebusinessresearchcompany.com/report/adme-toxicology-testing-global-market-report

Where Is The ADME Toxicology Testing Market Most Concentrated Geographically?

North America was the largest region in the ADME toxicology testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the adme toxicology testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized ADME Toxicology Testing Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/adme-toxicology-testing-global-market-report

Browse Through More Reports Similar to the Global ADME Toxicology Testing Market 2026, By The Business Research Company

In Vitro Toxicology Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/in-vitro-toxicology-testing-global-market-report

Pharma Admet Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/pharma-admet-testing-global-market-report

Genetic Toxicology Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/genetic-toxicology-testing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795